Nordic Life Science 1
Analytical Testing of Novel Biological Drugs Your
trusted partner for analytical procedures. From assessing early development test methods to conducting routine testing of drug products. Key Focus Areas • Advanced Therapies: Cell and Gene Therapies • Vaccines: mRNA and DNA Vaccines • Biologics: Cell Bank Characterization Overview of Our Analytical Portfolio • Identity Testing: Sequence and Strain Identity • Copy Number Analysis: Vector and Transgene Copy Number (VCN) • CRISPR Analysis: Translocations, On-Target-Assays, and Off-Target-Assays Key Certificates • ISO 13485:2016 • EN ISO 17025:2017 • GMP certified (Swissmedic) for testing of TpP/TP/GMO Microsynth – A Proven Contract Research Organization Download our new white paper: “Guide to GxP-compliant Analytical Testing of Novel Biological Drugs“. Microsynth AG, Switzerland Schützenstrasse 15 P.O. Box · CH - 9436 Balgach Phone + 41 71 722 83 33 info@microsynth.ch www.microsynth.com